Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.00900653 |
2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.00900653 |
3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.54044281 |
4 | negative regulation of cell killing (GO:0031342) | 5.25044312 |
5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.25044312 |
6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.13257617 |
7 | response to type I interferon (GO:0034340) | 4.46890227 |
8 | cellular response to type I interferon (GO:0071357) | 4.45785393 |
9 | type I interferon signaling pathway (GO:0060337) | 4.45785393 |
10 | positive regulation of interferon-alpha production (GO:0032727) | 4.23124924 |
11 | detection of other organism (GO:0098543) | 4.18915639 |
12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.16815392 |
13 | detection of molecule of bacterial origin (GO:0032490) | 4.14296069 |
14 | negative regulation of interleukin-12 production (GO:0032695) | 4.05028686 |
15 | regulation of interferon-alpha production (GO:0032647) | 4.00142231 |
16 | detection of bacterium (GO:0016045) | 3.96621292 |
17 | detection of external biotic stimulus (GO:0098581) | 3.89261703 |
18 | response to interferon-alpha (GO:0035455) | 3.72377786 |
19 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.67104795 |
20 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.57643612 |
21 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.56706035 |
22 | negative regulation of T cell mediated immunity (GO:0002710) | 3.55371372 |
23 | microglial cell activation (GO:0001774) | 3.50067776 |
24 | positive regulation by symbiont of host defense response (GO:0052509) | 3.46083032 |
25 | modulation by symbiont of host defense response (GO:0052031) | 3.46083032 |
26 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.46083032 |
27 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.46083032 |
28 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.46083032 |
29 | modulation by symbiont of host immune response (GO:0052553) | 3.46083032 |
30 | detection of biotic stimulus (GO:0009595) | 3.40817821 |
31 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.40579758 |
32 | response to interleukin-15 (GO:0070672) | 3.37572603 |
33 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.35848820 |
34 | regulation of regulatory T cell differentiation (GO:0045589) | 3.33649363 |
35 | regulation of RIG-I signaling pathway (GO:0039535) | 3.32428555 |
36 | immunoglobulin mediated immune response (GO:0016064) | 3.29576854 |
37 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.26138516 |
38 | macrophage activation (GO:0042116) | 3.26034415 |
39 | neutrophil activation involved in immune response (GO:0002283) | 3.24948269 |
40 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.23066373 |
41 | response to host (GO:0075136) | 3.23066373 |
42 | response to host defenses (GO:0052200) | 3.23066373 |
43 | NIK/NF-kappaB signaling (GO:0038061) | 3.22609821 |
44 | cellular extravasation (GO:0045123) | 3.21470913 |
45 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.19509052 |
46 | negative regulation of viral genome replication (GO:0045071) | 3.17565895 |
47 | regulation of T cell tolerance induction (GO:0002664) | 3.17338928 |
48 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.16926510 |
49 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.15973224 |
50 | leukocyte aggregation (GO:0070486) | 3.13962592 |
51 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.13127968 |
52 | cellular response to interferon-beta (GO:0035458) | 3.12953221 |
53 | response to interferon-beta (GO:0035456) | 3.12100366 |
54 | cellular response to interleukin-15 (GO:0071350) | 3.11687741 |
55 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.11087001 |
56 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.11031097 |
57 | positive regulation of interferon-beta production (GO:0032728) | 3.10490752 |
58 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.09984834 |
59 | regulation of gamma-delta T cell activation (GO:0046643) | 3.09138230 |
60 | positive regulation of humoral immune response (GO:0002922) | 3.09102867 |
61 | response to peptidoglycan (GO:0032494) | 3.08791488 |
62 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.04824459 |
63 | regulation of tolerance induction (GO:0002643) | 3.03611826 |
64 | negative T cell selection (GO:0043383) | 3.02642185 |
65 | negative thymic T cell selection (GO:0045060) | 3.02546397 |
66 | interferon-gamma secretion (GO:0072643) | 3.01332321 |
67 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.01186740 |
68 | positive regulation of type 2 immune response (GO:0002830) | 3.01108662 |
69 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.00368763 |
70 | response to interferon-gamma (GO:0034341) | 2.97817509 |
71 | regulation of antigen processing and presentation (GO:0002577) | 2.97646156 |
72 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.95286987 |
73 | germinal center formation (GO:0002467) | 2.93217672 |
74 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.91657612 |
75 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.90666607 |
76 | myeloid cell activation involved in immune response (GO:0002275) | 2.89578006 |
77 | complement activation, alternative pathway (GO:0006957) | 2.88106111 |
78 | neutrophil activation (GO:0042119) | 2.87080749 |
79 | negative regulation of innate immune response (GO:0045824) | 2.86090343 |
80 | cellular response to virus (GO:0098586) | 2.85668592 |
81 | regulation of cholesterol storage (GO:0010885) | 2.85343092 |
82 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.85271014 |
83 | phospholipid efflux (GO:0033700) | 2.84988154 |
84 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.82932641 |
85 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.82811448 |
86 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.81706722 |
87 | protein carboxylation (GO:0018214) | 2.81706722 |
88 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.81682736 |
89 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.80231210 |
90 | natural killer cell mediated immunity (GO:0002228) | 2.80231210 |
91 | response to protozoan (GO:0001562) | 2.80023748 |
92 | B cell receptor signaling pathway (GO:0050853) | 2.78902347 |
93 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.78626010 |
94 | tolerance induction (GO:0002507) | 2.78625788 |
95 | macrophage activation involved in immune response (GO:0002281) | 2.77585236 |
96 | B cell mediated immunity (GO:0019724) | 2.77315649 |
97 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.77247073 |
98 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.76680868 |
99 | positive regulation of antigen processing and presentation (GO:0002579) | 2.76360030 |
100 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.75848157 |
101 | plasma lipoprotein particle clearance (GO:0034381) | 2.75446000 |
102 | dendritic cell chemotaxis (GO:0002407) | 2.74832393 |
103 | low-density lipoprotein particle clearance (GO:0034383) | 2.74516333 |
104 | urea metabolic process (GO:0019627) | 2.74028368 |
105 | urea cycle (GO:0000050) | 2.74028368 |
106 | dendritic cell migration (GO:0036336) | 2.73257992 |
107 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.73042378 |
108 | negative regulation of lipid storage (GO:0010888) | 2.72471528 |
109 | regulation of natural killer cell differentiation (GO:0032823) | 2.72393514 |
110 | positive regulation of tolerance induction (GO:0002645) | 2.70918895 |
111 | cellular response to interferon-alpha (GO:0035457) | 2.69348074 |
112 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.68410611 |
113 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.67952291 |
114 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.67952291 |
115 | T cell migration (GO:0072678) | 2.67861682 |
116 | tryptophan catabolic process (GO:0006569) | 2.67809221 |
117 | indole-containing compound catabolic process (GO:0042436) | 2.67809221 |
118 | indolalkylamine catabolic process (GO:0046218) | 2.67809221 |
119 | cellular response to exogenous dsRNA (GO:0071360) | 2.64581538 |
120 | respiratory burst (GO:0045730) | 2.64379865 |
121 | T-helper 1 type immune response (GO:0042088) | 2.63949050 |
122 | aromatic amino acid family catabolic process (GO:0009074) | 2.63189540 |
123 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.62289395 |
124 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.61696159 |
125 | defense response to protozoan (GO:0042832) | 2.60413178 |
126 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.60396009 |
127 | positive regulation of B cell differentiation (GO:0045579) | 2.59329659 |
128 | high-density lipoprotein particle remodeling (GO:0034375) | 2.57738731 |
129 | kynurenine metabolic process (GO:0070189) | 2.56377123 |
130 | tryptophan metabolic process (GO:0006568) | 2.56074733 |
131 | regulation of cholesterol esterification (GO:0010872) | 2.55761150 |
132 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.53310947 |
133 | L-phenylalanine catabolic process (GO:0006559) | 2.53310947 |
134 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.52957339 |
135 | alpha-linolenic acid metabolic process (GO:0036109) | 2.52912005 |
136 | acute-phase response (GO:0006953) | 2.52581821 |
137 | regulation of protein activation cascade (GO:2000257) | 2.52413758 |
138 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.52149381 |
139 | response to host immune response (GO:0052572) | 2.52149381 |
140 | granulocyte activation (GO:0036230) | 2.51560242 |
141 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.50803193 |
142 | cellular response to interferon-gamma (GO:0071346) | 2.50212486 |
143 | regulation of triglyceride catabolic process (GO:0010896) | 2.49216708 |
144 | positive regulation of interleukin-12 production (GO:0032735) | 2.48364325 |
145 | phospholipid homeostasis (GO:0055091) | 2.47861376 |
146 | reactive oxygen species biosynthetic process (GO:1903409) | 2.47550520 |
147 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.46691006 |
148 | * regulation of response to interferon-gamma (GO:0060330) | 2.46691006 |
149 | valine metabolic process (GO:0006573) | 2.46580358 |
150 | nitrogen cycle metabolic process (GO:0071941) | 2.46044415 |
151 | regulation of hypersensitivity (GO:0002883) | 2.45298607 |
152 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.44821027 |
153 | defense response to virus (GO:0051607) | 2.42844840 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.57374609 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.84345329 |
3 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.73559547 |
4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.55132094 |
5 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.02660984 |
6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.73591530 |
7 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.29735151 |
8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.14781713 |
9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.09387289 |
10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.08269477 |
11 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.07785778 |
12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.01315218 |
13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.86637045 |
14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.82047297 |
15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.77241199 |
16 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.68580513 |
17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.61744634 |
18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.57485471 |
19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.55860787 |
20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.42554838 |
21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.41649599 |
22 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.41199927 |
23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.40587668 |
24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.27839050 |
25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.27737070 |
26 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.26313838 |
27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.24914701 |
28 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.21999629 |
29 | GATA1_22025678_ChIP-Seq_K562_Human | 2.21059369 |
30 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.18589115 |
31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.98034397 |
32 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.94517275 |
33 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.82636400 |
34 | MYB_26560356_Chip-Seq_TH2_Human | 1.80009797 |
35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.77302757 |
36 | MAF_26560356_Chip-Seq_TH1_Human | 1.72990141 |
37 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.66104914 |
38 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.65777688 |
39 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.63668083 |
40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.63604064 |
41 | MYB_26560356_Chip-Seq_TH1_Human | 1.62127779 |
42 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.61071929 |
43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57279706 |
44 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.55732596 |
45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.50948623 |
46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.36223925 |
47 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35852789 |
48 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.34996853 |
49 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.33706958 |
50 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.33211765 |
51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30936860 |
52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.29640033 |
53 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.28834811 |
54 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28058160 |
55 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.27479916 |
56 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26675482 |
57 | UTX_26944678_Chip-Seq_JUKART_Human | 1.26528697 |
58 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.25092523 |
59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24260664 |
60 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23009113 |
61 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.17266768 |
62 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17103024 |
63 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.17075201 |
64 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14820403 |
65 | MYC_22102868_ChIP-Seq_BL_Human | 1.14516708 |
66 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.13735837 |
67 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.11532588 |
68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07578076 |
69 | SPI1_23127762_ChIP-Seq_K562_Human | 1.06758827 |
70 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05411577 |
71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04475763 |
72 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00776198 |
73 | MAF_26560356_Chip-Seq_TH2_Human | 1.00435436 |
74 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00282772 |
75 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98560104 |
76 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96521367 |
77 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96420825 |
78 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.96338381 |
79 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95388307 |
80 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.95018383 |
81 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95007507 |
82 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94609671 |
83 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94605067 |
84 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93215073 |
85 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91839710 |
86 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90803766 |
87 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89887138 |
88 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.88861493 |
89 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88380339 |
90 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87196467 |
91 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.87047303 |
92 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.86620115 |
93 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.85623918 |
94 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.85537479 |
95 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.84714674 |
96 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.84554655 |
97 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83643802 |
98 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.82979859 |
99 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82518597 |
100 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82099435 |
101 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.81833193 |
102 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.81576166 |
103 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81416944 |
104 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80846678 |
105 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.80556536 |
106 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.79212768 |
107 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78742587 |
108 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.77523586 |
109 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.76341249 |
110 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.75510118 |
111 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75038930 |
112 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.74983586 |
113 | GATA2_19941826_ChIP-Seq_K562_Human | 0.74565190 |
114 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.71886532 |
115 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.71139712 |
116 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.66603307 |
117 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65516553 |
118 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.65379594 |
119 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.64934114 |
120 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.64904068 |
121 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.63973888 |
122 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.63355427 |
123 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.62831032 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.72046565 |
2 | MP0009785_altered_susceptibility_to | 3.18346754 |
3 | MP0002139_abnormal_hepatobiliary_system | 3.15314159 |
4 | MP0005360_urolithiasis | 3.10095012 |
5 | MP0003436_decreased_susceptibility_to | 2.81737659 |
6 | MP0000685_abnormal_immune_system | 2.78318574 |
7 | MP0003724_increased_susceptibility_to | 2.69171428 |
8 | MP0005025_abnormal_response_to | 2.46719733 |
9 | MP0001790_abnormal_immune_system | 2.44607953 |
10 | MP0005387_immune_system_phenotype | 2.44607953 |
11 | MP0003191_abnormal_cellular_cholesterol | 2.38757704 |
12 | MP0009840_abnormal_foam_cell | 2.38659710 |
13 | MP0005000_abnormal_immune_tolerance | 2.33828098 |
14 | MP0002148_abnormal_hypersensitivity_rea | 2.31457410 |
15 | MP0005671_abnormal_response_to | 2.31256850 |
16 | MP0006082_CNS_inflammation | 2.30906420 |
17 | MP0005365_abnormal_bile_salt | 2.27589331 |
18 | MP0005085_abnormal_gallbladder_physiolo | 2.27470693 |
19 | MP0001800_abnormal_humoral_immune | 2.25863306 |
20 | MP0002419_abnormal_innate_immunity | 2.23456766 |
21 | MP0003303_peritoneal_inflammation | 2.09743426 |
22 | MP0002452_abnormal_antigen_presenting | 2.08383203 |
23 | MP0002723_abnormal_immune_serum | 2.06551126 |
24 | MP0002166_altered_tumor_susceptibility | 1.99953582 |
25 | MP0004947_skin_inflammation | 1.92026900 |
26 | MP0002138_abnormal_hepatobiliary_system | 1.89448745 |
27 | MP0008875_abnormal_xenobiotic_pharmacok | 1.87143754 |
28 | MP0005464_abnormal_platelet_physiology | 1.85416173 |
29 | MP0002006_tumorigenesis | 1.84694618 |
30 | MP0001819_abnormal_immune_cell | 1.82379254 |
31 | MP0002420_abnormal_adaptive_immunity | 1.80065167 |
32 | MP0001853_heart_inflammation | 1.74394752 |
33 | MP0008469_abnormal_protein_level | 1.74231339 |
34 | MP0009764_decreased_sensitivity_to | 1.73145430 |
35 | MP0003252_abnormal_bile_duct | 1.70534784 |
36 | MP0010155_abnormal_intestine_physiology | 1.66520266 |
37 | MP0004510_myositis | 1.66125133 |
38 | MP0001845_abnormal_inflammatory_respons | 1.65640928 |
39 | MP0005058_abnormal_lysosome_morphology | 1.63225682 |
40 | MP0010329_abnormal_lipoprotein_level | 1.57320833 |
41 | MP0003300_gastrointestinal_ulcer | 1.57050044 |
42 | MP0003763_abnormal_thymus_physiology | 1.54069534 |
43 | MP0001533_abnormal_skeleton_physiology | 1.51521075 |
44 | MP0003045_fibrosis | 1.48177675 |
45 | MP0000609_abnormal_liver_physiology | 1.46635578 |
46 | MP0002405_respiratory_system_inflammati | 1.45600429 |
47 | MP0000716_abnormal_immune_system | 1.45050272 |
48 | MP0002398_abnormal_bone_marrow | 1.42490534 |
49 | MP0002254_reproductive_system_inflammat | 1.36508814 |
50 | MP0005083_abnormal_biliary_tract | 1.34078853 |
51 | MP0003806_abnormal_nucleotide_metabolis | 1.33919355 |
52 | MP0000569_abnormal_digit_pigmentation | 1.32013786 |
53 | MP0005397_hematopoietic_system_phenotyp | 1.30520228 |
54 | MP0001545_abnormal_hematopoietic_system | 1.30520228 |
55 | MP0009763_increased_sensitivity_to | 1.29438209 |
56 | MP0003186_abnormal_redox_activity | 1.27555248 |
57 | MP0000689_abnormal_spleen_morphology | 1.25786734 |
58 | MP0004883_abnormal_blood_vessel | 1.24177596 |
59 | MP0009333_abnormal_splenocyte_physiolog | 1.22896315 |
60 | MP0003448_altered_tumor_morphology | 1.22187113 |
61 | MP0008260_abnormal_autophagy | 1.20228085 |
62 | MP0003705_abnormal_hypodermis_morpholog | 1.19926601 |
63 | MP0005319_abnormal_enzyme/_coenzyme | 1.19734491 |
64 | MP0002429_abnormal_blood_cell | 1.19159464 |
65 | MP0002722_abnormal_immune_system | 1.18347816 |
66 | MP0003183_abnormal_peptide_metabolism | 1.17573649 |
67 | MP0005164_abnormal_response_to | 1.17269499 |
68 | MP0009278_abnormal_bone_marrow | 1.15700073 |
69 | MP0002277_abnormal_respiratory_mucosa | 1.15467057 |
70 | MP0001666_abnormal_nutrient_absorption | 1.15407252 |
71 | MP0000858_altered_metastatic_potential | 1.14288670 |
72 | MP0010352_gastrointestinal_tract_polyps | 1.08707021 |
73 | MP0005310_abnormal_salivary_gland | 1.05663895 |
74 | MP0004381_abnormal_hair_follicle | 1.04612107 |
75 | MP0000343_altered_response_to | 1.02082182 |
76 | MP0004782_abnormal_surfactant_physiolog | 1.01287745 |
77 | MP0005332_abnormal_amino_acid | 1.00613433 |
78 | MP0003075_altered_response_to | 1.00602915 |
79 | MP0005075_abnormal_melanosome_morpholog | 1.00272738 |
80 | MP0003453_abnormal_keratinocyte_physiol | 1.00035946 |
81 | MP0003195_calcinosis | 0.99062123 |
82 | MP0001873_stomach_inflammation | 0.98379456 |
83 | MP0003690_abnormal_glial_cell | 0.98255313 |
84 | MP0010234_abnormal_vibrissa_follicle | 0.97999856 |
85 | MP0000604_amyloidosis | 0.97924083 |
86 | MP0001851_eye_inflammation | 0.97650833 |
87 | MP0002998_abnormal_bone_remodeling | 0.95355881 |
88 | MP0006054_spinal_hemorrhage | 0.94450483 |
89 | MP0003656_abnormal_erythrocyte_physiolo | 0.93411807 |
90 | MP0002118_abnormal_lipid_homeostasis | 0.92417035 |
91 | MP0000598_abnormal_liver_morphology | 0.91962313 |
92 | MP0003172_abnormal_lysosome_physiology | 0.91807403 |
93 | MP0009643_abnormal_urine_homeostasis | 0.91678650 |
94 | MP0003828_pulmonary_edema | 0.91590311 |
95 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.91393518 |
96 | MP0002132_abnormal_respiratory_system | 0.88790404 |
97 | MP0005166_decreased_susceptibility_to | 0.87465981 |
98 | MP0010307_abnormal_tumor_latency | 0.87338679 |
99 | MP0002396_abnormal_hematopoietic_system | 0.86464483 |
100 | MP0002136_abnormal_kidney_physiology | 0.81562461 |
101 | MP0002332_abnormal_exercise_endurance | 0.80928411 |
102 | MP0005023_abnormal_wound_healing | 0.80652921 |
103 | MP0009765_abnormal_xenobiotic_induced | 0.80395525 |
104 | MP0002693_abnormal_pancreas_physiology | 0.80015147 |
105 | MP0004019_abnormal_vitamin_homeostasis | 0.79960786 |
106 | MP0004808_abnormal_hematopoietic_stem | 0.78291473 |
107 | MP0003566_abnormal_cell_adhesion | 0.77942841 |
108 | MP0005167_abnormal_blood-brain_barrier | 0.77677476 |
109 | MP0002933_joint_inflammation | 0.77488544 |
110 | MP0003866_abnormal_defecation | 0.74780919 |
111 | MP0000249_abnormal_blood_vessel | 0.74482804 |
112 | MP0001663_abnormal_digestive_system | 0.73672323 |
113 | MP0005390_skeleton_phenotype | 0.73463123 |
114 | MP0003091_abnormal_cell_migration | 0.73131688 |
115 | MP0005451_abnormal_body_composition | 0.72580624 |
116 | MP0001764_abnormal_homeostasis | 0.71188134 |
117 | MP0000015_abnormal_ear_pigmentation | 0.71035039 |
118 | MP0001881_abnormal_mammary_gland | 0.70584583 |
119 | MP0000703_abnormal_thymus_morphology | 0.69998330 |
120 | MP0002168_other_aberrant_phenotype | 0.69969703 |
121 | MP0000465_gastrointestinal_hemorrhage | 0.68092202 |
122 | MP0008004_abnormal_stomach_pH | 0.65444242 |
123 | MP0003795_abnormal_bone_structure | 0.65175674 |
124 | MP0000371_diluted_coat_color | 0.64905616 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 4.88266794 |
2 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.48760203 |
3 | Autoimmune thrombocytopenia (HP:0001973) | 4.32221276 |
4 | Recurrent abscess formation (HP:0002722) | 4.29729103 |
5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.13410817 |
6 | Recurrent bacterial skin infections (HP:0005406) | 4.11449230 |
7 | Systemic lupus erythematosus (HP:0002725) | 3.74549594 |
8 | Chronic otitis media (HP:0000389) | 3.58359529 |
9 | Myositis (HP:0100614) | 3.43165807 |
10 | Keratoconjunctivitis (HP:0001096) | 3.37501029 |
11 | Joint hemorrhage (HP:0005261) | 3.35237223 |
12 | Deep venous thrombosis (HP:0002625) | 3.34130655 |
13 | Recurrent viral infections (HP:0004429) | 3.33416524 |
14 | Recurrent fungal infections (HP:0002841) | 3.26941018 |
15 | Mediastinal lymphadenopathy (HP:0100721) | 3.21508790 |
16 | Abnormality of macrophages (HP:0004311) | 3.21410947 |
17 | Xanthomatosis (HP:0000991) | 3.20841475 |
18 | Complement deficiency (HP:0004431) | 3.19019919 |
19 | Encephalitis (HP:0002383) | 3.16629271 |
20 | Orchitis (HP:0100796) | 3.14099973 |
21 | Vasculitis (HP:0002633) | 3.13863367 |
22 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.11634140 |
23 | Recurrent skin infections (HP:0001581) | 3.10996688 |
24 | Prolonged partial thromboplastin time (HP:0003645) | 3.09099864 |
25 | Intrahepatic cholestasis (HP:0001406) | 3.06354513 |
26 | Gingival bleeding (HP:0000225) | 3.02895069 |
27 | Myocardial infarction (HP:0001658) | 3.02337114 |
28 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.99479921 |
29 | Abnormality of the common coagulation pathway (HP:0010990) | 2.98303039 |
30 | Nasal polyposis (HP:0100582) | 2.96697730 |
31 | Recurrent bronchitis (HP:0002837) | 2.89723697 |
32 | Increased IgM level (HP:0003496) | 2.86727466 |
33 | Abnormality of the nasal mucosa (HP:0000433) | 2.83864338 |
34 | Optic neuritis (HP:0100653) | 2.76908256 |
35 | Retrobulbar optic neuritis (HP:0100654) | 2.76908256 |
36 | Hypobetalipoproteinemia (HP:0003563) | 2.74042279 |
37 | Abnormality of T cell number (HP:0011839) | 2.72419172 |
38 | Stomatitis (HP:0010280) | 2.72029913 |
39 | Vacuolated lymphocytes (HP:0001922) | 2.71740115 |
40 | Pustule (HP:0200039) | 2.69710537 |
41 | Gingivitis (HP:0000230) | 2.69247227 |
42 | Chest pain (HP:0100749) | 2.67723270 |
43 | Periodontitis (HP:0000704) | 2.63135822 |
44 | Abnormality of complement system (HP:0005339) | 2.61232294 |
45 | Interstitial pulmonary disease (HP:0006530) | 2.60034973 |
46 | Autoimmune hemolytic anemia (HP:0001890) | 2.59113872 |
47 | Inflammation of the large intestine (HP:0002037) | 2.56713454 |
48 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.55638459 |
49 | Gastrointestinal infarctions (HP:0005244) | 2.54990795 |
50 | Gangrene (HP:0100758) | 2.54267697 |
51 | Peritonitis (HP:0002586) | 2.53606785 |
52 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.51128936 |
53 | Recurrent cutaneous fungal infections (HP:0011370) | 2.49777375 |
54 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.49777375 |
55 | Joint swelling (HP:0001386) | 2.49203963 |
56 | Prolonged bleeding time (HP:0003010) | 2.47674756 |
57 | T lymphocytopenia (HP:0005403) | 2.47075241 |
58 | Spontaneous hematomas (HP:0007420) | 2.45684039 |
59 | Chronic diarrhea (HP:0002028) | 2.45416069 |
60 | Arterial thrombosis (HP:0004420) | 2.44938665 |
61 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.44474319 |
62 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.44474319 |
63 | Abnormality of glycolipid metabolism (HP:0010969) | 2.44474319 |
64 | Loss of speech (HP:0002371) | 2.43281705 |
65 | Gastrointestinal inflammation (HP:0004386) | 2.43216806 |
66 | Esophageal varix (HP:0002040) | 2.42455181 |
67 | Hypergammaglobulinemia (HP:0010702) | 2.41694125 |
68 | Hyperlipoproteinemia (HP:0010980) | 2.40561202 |
69 | Glomerulonephritis (HP:0000099) | 2.39284258 |
70 | Tetraparesis (HP:0002273) | 2.38314682 |
71 | Nephritis (HP:0000123) | 2.38252643 |
72 | Pulmonary infiltrates (HP:0002113) | 2.37927545 |
73 | Abnormality of T cells (HP:0002843) | 2.37489469 |
74 | Epistaxis (HP:0000421) | 2.37056482 |
75 | Epidermoid cyst (HP:0200040) | 2.36930031 |
76 | Basal ganglia calcification (HP:0002135) | 2.36336465 |
77 | Abnormality of T cell physiology (HP:0011840) | 2.35529242 |
78 | Abnormality of the pleura (HP:0002103) | 2.34631723 |
79 | Cellulitis (HP:0100658) | 2.33969324 |
80 | Urticaria (HP:0001025) | 2.32210725 |
81 | Hematochezia (HP:0002573) | 2.31307783 |
82 | Meningitis (HP:0001287) | 2.29449972 |
83 | Thrombophlebitis (HP:0004418) | 2.26951520 |
84 | Malnutrition (HP:0004395) | 2.26854081 |
85 | Hypochromic microcytic anemia (HP:0004840) | 2.23632883 |
86 | Hypochromic anemia (HP:0001931) | 2.23260509 |
87 | Colitis (HP:0002583) | 2.22355818 |
88 | Eosinophilia (HP:0001880) | 2.22251976 |
89 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.22166139 |
90 | Pulmonary embolism (HP:0002204) | 2.21495427 |
91 | Leukocytosis (HP:0001974) | 2.20146894 |
92 | IgG deficiency (HP:0004315) | 2.19174686 |
93 | Cheilitis (HP:0100825) | 2.19069402 |
94 | Hemoptysis (HP:0002105) | 2.18810508 |
95 | Panhypogammaglobulinemia (HP:0003139) | 2.18655668 |
96 | Episodic fever (HP:0001954) | 2.18530383 |
97 | Hypercholesterolemia (HP:0003124) | 2.17573621 |
98 | Hemorrhage of the eye (HP:0011885) | 2.15247209 |
99 | Keratoconjunctivitis sicca (HP:0001097) | 2.13291095 |
100 | Thrombocytosis (HP:0001894) | 2.13113484 |
101 | Acne (HP:0001061) | 2.12680913 |
102 | Fat malabsorption (HP:0002630) | 2.12302378 |
103 | Abnormality of the intrinsic pathway (HP:0010989) | 2.11115158 |
104 | Osteomyelitis (HP:0002754) | 2.09922093 |
105 | IgA deficiency (HP:0002720) | 2.09537714 |
106 | Abnormality of the endocardium (HP:0004306) | 2.08768521 |
107 | Anorexia (HP:0002039) | 2.08215636 |
108 | Hypolipoproteinemia (HP:0010981) | 2.07560012 |
109 | Purpura (HP:0000979) | 2.06659157 |
110 | Abnormality of eosinophils (HP:0001879) | 2.05478391 |
111 | Acute hepatic failure (HP:0006554) | 2.04733000 |
112 | IgM deficiency (HP:0002850) | 2.04405422 |
113 | Menorrhagia (HP:0000132) | 2.04258082 |
114 | Premature loss of primary teeth (HP:0006323) | 2.04049322 |
115 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.03823804 |
116 | Amyloidosis (HP:0011034) | 2.03537684 |
117 | Hyperammonemia (HP:0001987) | 2.03361889 |
118 | Increased IgE level (HP:0003212) | 2.02383282 |
119 | Axonal loss (HP:0003447) | 2.02222948 |
120 | Granulocytopenia (HP:0001913) | 2.02112548 |
121 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.01756963 |
122 | Abnormality of iron homeostasis (HP:0011031) | 2.01665598 |
123 | Chronic obstructive pulmonary disease (HP:0006510) | 2.00903107 |
124 | Obstructive lung disease (HP:0006536) | 2.00903107 |
125 | Agammaglobulinemia (HP:0004432) | 2.00643561 |
126 | Petechiae (HP:0000967) | 1.99354011 |
127 | Abnormality of the pericardium (HP:0001697) | 1.98954510 |
128 | Lymphopenia (HP:0001888) | 1.98873801 |
129 | Increased CSF protein (HP:0002922) | 1.98714882 |
130 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.98180426 |
131 | Increased serum ferritin (HP:0003281) | 1.98112476 |
132 | Osteolytic defects of the hand bones (HP:0009699) | 1.97872910 |
133 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.97872910 |
134 | Dysostosis multiplex (HP:0000943) | 1.95191021 |
135 | Gastrointestinal stroma tumor (HP:0100723) | 1.94272677 |
136 | Keratitis (HP:0000491) | 1.93703436 |
137 | Increased cerebral lipofuscin (HP:0011813) | 1.91338447 |
138 | Glomerulopathy (HP:0100820) | 1.89372226 |
139 | Microcytic anemia (HP:0001935) | 1.89177262 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TYK2 | 3.74383564 |
2 | MAP3K14 | 3.62935807 |
3 | MAP4K1 | 3.39346175 |
4 | TBK1 | 3.23955230 |
5 | FGFR4 | 3.22226767 |
6 | JAK3 | 3.05992172 |
7 | IKBKE | 2.97647289 |
8 | ERN1 | 2.64147874 |
9 | TXK | 2.56513693 |
10 | JAK1 | 2.55218874 |
11 | MAP3K10 | 2.32839641 |
12 | KIT | 2.30093311 |
13 | IRAK3 | 2.13060760 |
14 | BLK | 2.09892436 |
15 | IRAK4 | 2.08682417 |
16 | IKBKB | 1.95817096 |
17 | ZAP70 | 1.87155440 |
18 | FGFR3 | 1.74177266 |
19 | MAP3K13 | 1.65747312 |
20 | FLT3 | 1.63642715 |
21 | RIPK4 | 1.51499879 |
22 | PKN2 | 1.50252383 |
23 | TAOK3 | 1.49884620 |
24 | FGR | 1.43948328 |
25 | EPHB1 | 1.43889437 |
26 | TNK2 | 1.43420217 |
27 | CSK | 1.42592384 |
28 | SIK1 | 1.40212248 |
29 | PBK | 1.38926905 |
30 | EPHA3 | 1.33685777 |
31 | NEK9 | 1.33027770 |
32 | PRPF4B | 1.32509097 |
33 | CHUK | 1.29839806 |
34 | JAK2 | 1.29723062 |
35 | NME2 | 1.29624506 |
36 | TRIB3 | 1.28202890 |
37 | CSF1R | 1.27703917 |
38 | SYK | 1.27628526 |
39 | BTK | 1.25432144 |
40 | RPS6KA4 | 1.21576242 |
41 | STK10 | 1.20870225 |
42 | TGFBR2 | 1.20529779 |
43 | MAP3K2 | 1.18989158 |
44 | MAP2K3 | 1.18275731 |
45 | TAOK1 | 1.15177911 |
46 | HCK | 1.15017528 |
47 | MST4 | 1.14003105 |
48 | LCK | 1.11371621 |
49 | TEC | 1.09372062 |
50 | NLK | 1.03937013 |
51 | PTK6 | 1.02680976 |
52 | HIPK2 | 1.02256914 |
53 | ITK | 1.02189122 |
54 | MAP3K3 | 1.02033654 |
55 | PIM2 | 1.00122481 |
56 | BCKDK | 0.98963035 |
57 | GRK7 | 0.96987810 |
58 | LRRK2 | 0.96390859 |
59 | PIM1 | 0.95938344 |
60 | KDR | 0.95351056 |
61 | GRK6 | 0.90142849 |
62 | MAPK11 | 0.88499725 |
63 | CDC42BPA | 0.88260283 |
64 | LYN | 0.84542823 |
65 | MST1R | 0.82293490 |
66 | STK4 | 0.81873410 |
67 | YES1 | 0.81720841 |
68 | IRAK2 | 0.80925014 |
69 | RIPK1 | 0.79365805 |
70 | IRAK1 | 0.78273658 |
71 | PTK2B | 0.75844483 |
72 | MAP2K6 | 0.74298053 |
73 | CDK6 | 0.73621474 |
74 | MAP3K11 | 0.71936835 |
75 | MARK3 | 0.68419876 |
76 | TRPM7 | 0.66513256 |
77 | TTN | 0.62679420 |
78 | STK3 | 0.60680715 |
79 | CAMKK2 | 0.59843584 |
80 | MAP3K5 | 0.59590605 |
81 | MATK | 0.58226213 |
82 | SIK3 | 0.57107598 |
83 | FRK | 0.56889171 |
84 | PDPK1 | 0.56815106 |
85 | MAPK7 | 0.53055715 |
86 | FER | 0.52787752 |
87 | BMX | 0.52246325 |
88 | PRKD2 | 0.51384455 |
89 | KSR2 | 0.50835717 |
90 | CDK4 | 0.50640696 |
91 | PIK3CG | 0.49884402 |
92 | ABL2 | 0.48933084 |
93 | ABL1 | 0.48407091 |
94 | MAP3K6 | 0.47852123 |
95 | EGFR | 0.47132014 |
96 | TGFBR1 | 0.46698652 |
97 | PRKCQ | 0.46385092 |
98 | TAOK2 | 0.46304967 |
99 | EEF2K | 0.46251502 |
100 | EIF2AK2 | 0.45663563 |
101 | DAPK2 | 0.45231230 |
102 | ADRBK2 | 0.40279505 |
103 | FYN | 0.38926405 |
104 | MELK | 0.38625380 |
105 | PRKCD | 0.38427674 |
106 | CAMK1D | 0.38310294 |
107 | RET | 0.36498021 |
108 | MAP3K1 | 0.36247692 |
109 | STK24 | 0.35494352 |
110 | FES | 0.32904158 |
111 | STK38 | 0.32546431 |
112 | ACVR1B | 0.32269769 |
113 | IGF1R | 0.32015780 |
114 | SGK3 | 0.31111766 |
115 | MAPK12 | 0.30594936 |
116 | MARK2 | 0.30255978 |
117 | MAP3K12 | 0.28901496 |
118 | CDK12 | 0.28884520 |
119 | DYRK1B | 0.28878488 |
120 | PRKG2 | 0.28237975 |
121 | PDK1 | 0.27863613 |
122 | MAPKAPK2 | 0.27487607 |
123 | MAPKAPK3 | 0.27264640 |
124 | NUAK1 | 0.27195535 |
125 | STK11 | 0.27162105 |
126 | MAP3K8 | 0.27048751 |
127 | MAPK4 | 0.25793940 |
128 | INSRR | 0.25621360 |
129 | MAP2K2 | 0.25368833 |
130 | BMPR2 | 0.24475222 |
131 | MAP3K7 | 0.23790629 |
132 | TIE1 | 0.23579391 |
133 | PRKAA2 | 0.23394320 |
134 | PDGFRB | 0.20997037 |
135 | RPS6KA6 | 0.20803085 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.00440591 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.64669222 |
3 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.43218558 |
4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.34370057 |
5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.20370927 |
6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.19394446 |
7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.17506109 |
8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.13908698 |
9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.11523766 |
10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.07742563 |
11 | Measles_Homo sapiens_hsa05162 | 2.04460468 |
12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.00339431 |
13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.00254720 |
14 | Allograft rejection_Homo sapiens_hsa05330 | 1.99308915 |
15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.94593122 |
16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.85054080 |
17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.83136065 |
18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.75066594 |
19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.68524099 |
20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.68258278 |
21 | Legionellosis_Homo sapiens_hsa05134 | 1.65641573 |
22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.65504036 |
23 | Influenza A_Homo sapiens_hsa05164 | 1.56625820 |
24 | Pertussis_Homo sapiens_hsa05133 | 1.52363115 |
25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.48957675 |
26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.46141676 |
27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.41253361 |
28 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.41167915 |
29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.38212044 |
30 | Malaria_Homo sapiens_hsa05144 | 1.36794183 |
31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.35687500 |
32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.27736166 |
33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.27247462 |
34 | Peroxisome_Homo sapiens_hsa04146 | 1.25225422 |
35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17611699 |
36 | Tuberculosis_Homo sapiens_hsa05152 | 1.16921644 |
37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.15635805 |
38 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.10546081 |
39 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.05877573 |
40 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.05555228 |
41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.04621406 |
42 | Hepatitis C_Homo sapiens_hsa05160 | 1.04091268 |
43 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.03601991 |
44 | Histidine metabolism_Homo sapiens_hsa00340 | 1.03525702 |
45 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.03416045 |
46 | Apoptosis_Homo sapiens_hsa04210 | 1.02479024 |
47 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.01965938 |
48 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.01860874 |
49 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.95845301 |
50 | ABC transporters_Homo sapiens_hsa02010 | 0.95688091 |
51 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.94567636 |
52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.92436316 |
53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.92061700 |
54 | Asthma_Homo sapiens_hsa05310 | 0.87902080 |
55 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.87717929 |
56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.85256419 |
57 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.83930433 |
58 | Hepatitis B_Homo sapiens_hsa05161 | 0.83681749 |
59 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.83609057 |
60 | Retinol metabolism_Homo sapiens_hsa00830 | 0.82943997 |
61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.82050490 |
62 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.81935321 |
63 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.81730295 |
64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.80309492 |
65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.79889099 |
66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79580955 |
67 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.79406027 |
68 | Sulfur relay system_Homo sapiens_hsa04122 | 0.79077328 |
69 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.78744716 |
70 | Platelet activation_Homo sapiens_hsa04611 | 0.78173048 |
71 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.77994385 |
72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.77606289 |
73 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77523702 |
74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.75446649 |
75 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.73601370 |
76 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.72944413 |
77 | Lysosome_Homo sapiens_hsa04142 | 0.72361820 |
78 | Viral myocarditis_Homo sapiens_hsa05416 | 0.68389367 |
79 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.67530155 |
80 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.67059729 |
81 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.66835164 |
82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65381537 |
83 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.63557872 |
84 | Salmonella infection_Homo sapiens_hsa05132 | 0.63401225 |
85 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.61986462 |
86 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60372901 |
87 | Shigellosis_Homo sapiens_hsa05131 | 0.60244603 |
88 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.58887142 |
89 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.57284518 |
90 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.57246064 |
91 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.56079175 |
92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54056536 |
93 | Insulin resistance_Homo sapiens_hsa04931 | 0.54021924 |
94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53949577 |
95 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52427397 |
96 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.51809952 |
97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51246519 |
98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51045395 |
99 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.50390975 |
100 | Bile secretion_Homo sapiens_hsa04976 | 0.48860876 |
101 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47563585 |
102 | Phagosome_Homo sapiens_hsa04145 | 0.46679680 |
103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.45979927 |
104 | Prion diseases_Homo sapiens_hsa05020 | 0.45271391 |
105 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.44071079 |
106 | Amoebiasis_Homo sapiens_hsa05146 | 0.43748509 |
107 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42047171 |
108 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.41948252 |
109 | Other glycan degradation_Homo sapiens_hsa00511 | 0.41157103 |
110 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.40337302 |
111 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40049996 |
112 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.39981382 |
113 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37873854 |
114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35290031 |
115 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.34603208 |
116 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.34396586 |
117 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34250492 |
118 | Endocytosis_Homo sapiens_hsa04144 | 0.34244755 |
119 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34178251 |
120 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.32686440 |
121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32213192 |
122 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.29467353 |
123 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.28798869 |
124 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.28666076 |
125 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.28008936 |
126 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.26977041 |
127 | HTLV-I infection_Homo sapiens_hsa05166 | 0.26293273 |
128 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.25715851 |
129 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.24558560 |
130 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.24503883 |
131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23674429 |
132 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23487040 |
133 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.21486834 |
134 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.19638662 |
135 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.18664058 |